1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Colon Cancer Global Clinical Trials Review, H1, 2014

Colon Cancer Global Clinical Trials Review, H1, 2014

  • March 2014
  • -
  • Global Data
  • -
  • 120 pages

Colon Cancer Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Colon Cancer Global Clinical Trials Review, H1, 2014" provides data on the Colon Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Colon Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Colon Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Colon Cancer Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Colon Cancer 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Colon Cancer to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Colon Cancer to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Colon Cancer 25
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
Top Companies Participating in Colon Cancer Therapeutics Clinical Trials 32
Prominent Drugs 34
Latest Clinical Trials News on Colon Cancer 35
Oct 14, 2013: Reduced neurotoxicity with SPL's dendrimer enhanced oxaliplatin 35
Sep 11, 2013: Dendrimer-Oxaliplatin shows better anti-cancer efficacy and less toxicity 36
Jun 11, 2013: Novartis's AUY922 Shows Promise To Treat Breast And Lung Cancer In First-In-Human Phase I Trial 37
Jun 11, 2013: Critical Outcome Technologies Announces Positive Preclinical Results Of Cancer Drug Candidiate COTI-2 Against p53 Gene Mutations 38
May 20, 2013: PharmaMar Commences Phase Ib Trial With PM01183 In Combination With Capecitabine In Patients With Advanced Solid Tumors 38
Clinical Trial Profiles 40
Clinical Trial Overview of Top Companies 40
F. Hoffmann-La Roche Ltd. 40
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 40
Sanofi 42
Clinical Trial Overview of Sanofi 42
Pfizer Inc. 43
Clinical Trial Overview of Pfizer Inc. 43
Novartis AG 44
Clinical Trial Overview of Novartis AG 44
Amgen Inc. 45
Clinical Trial Overview of Amgen Inc. 45
GlaxoSmithKline plc 46
Clinical Trial Overview of GlaxoSmithKline plc 46
Immunomedics, Inc. 47
Clinical Trial Overview of Immunomedics, Inc. 47
Eli Lilly and Company 48
Clinical Trial Overview of Eli Lilly and Company 48
AstraZeneca PLC 49
Clinical Trial Overview of AstraZeneca PLC 49
Clinical Trial Overview of Top Institutes / Government 50
National Cancer Institute 50
Clinical Trial Overview of National Cancer Institute 50
Memorial Sloan Kettering Cancer Center 58
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 58
The University of Texas M. D. Anderson Cancer Center 60
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 60
Stanford University 61
Clinical Trial Overview of Stanford University 61
Barbara Ann Karmanos Cancer Institute 62
Clinical Trial Overview of Barbara Ann Karmanos Cancer Institute 62
Mayo Clinic 63
Clinical Trial Overview of Mayo Clinic 63
Ohio State University Comprehensive Cancer Center 64
Clinical Trial Overview of Ohio State University Comprehensive Cancer Center 64
Showa University Northern Yokohama Hospital 65
Clinical Trial Overview of Showa University Northern Yokohama Hospital 65
Alberta Health Services 66
Clinical Trial Overview of Alberta Health Services 66
Osaka Gastrointestinal Cancer Chemotherapy Study Group 67
Clinical Trial Overview of Osaka Gastrointestinal Cancer Chemotherapy Study Group 67
Five Key Clinical Profiles 68
Appendix 117
Abbreviations 117
Definitions 117
Research Methodology 118
Secondary Research 118
About GlobalData 119
Contact Us 119
Disclaimer 119
Source 120

List of Tables
Colon Cancer Therapeutics, Global, Clinical Trials by Region, 2014* 7
Colon Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Colon Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Colon Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Colon Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Colon Cancer Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Colon Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Colon Cancer Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Colon Cancer to Oncology Clinical Trials, G7 Countries (%), 2014* 15
Colon Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Colon Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Colon Cancer to Oncology Clinical Trials, E7 Countries (%), 2014* 18
Colon Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Colon Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Colon Cancer Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Colon Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Colon Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Colon Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Colon Cancer Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Colon Cancer Therapeutics, Global, Withdrawn Clinical Trials, 2014* 26
Colon Cancer Therapeutics, Global, Terminated Clinical Trials, 2014* 27
Colon Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 29
Colon Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 30
Colon Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 31
Colon Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 33
Colon Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 34
Colon Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 40
Colon Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 42
Colon Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 43
Colon Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 44
Colon Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014* 45
Colon Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 46
Colon Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Immunomedics, Inc., 2014* 47
Colon Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014* 48
Colon Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 49
Colon Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 50
Colon Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014* 58
Colon Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014* 60
Colon Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2014* 61
Colon Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Barbara Ann Karmanos Cancer Institute, 2014* 62
Colon Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2014* 63
Colon Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Ohio State University Comprehensive Cancer Center, 2014* 64
Colon Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Showa University Northern Yokohama Hospital, 2014* 65
Colon Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Alberta Health Services, 2014* 66
Colon Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Osaka Gastrointestinal Cancer Chemotherapy Study Group, 2014* 67

List of Figures
Colon Cancer Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Colon Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Colon Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Colon Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Colon Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Colon Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Colon Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Colon Cancer Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Colon Cancer to Oncology Clinical Trials, G7 Countries (%), 2014* 15
Colon Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Colon Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Colon Cancer to Oncology Clinical Trials, E7 Countries (%), 2014* 18
Colon Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Colon Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Colon Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Colon Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Colon Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Colon Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 29
Colon Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 30
Colon Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 31
Colon Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 32
Colon Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 34
GlobalData Methodology 118

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Hematological Cancers: Analytical Tool

Hematological Cancers: Analytical Tool

  • $ 11505
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

  • $ 6995
  • Industry report
  • September 2016
  • by GBI Research

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation Summary Glioblastoma multiforme (GBM) is a grade IV tumor that arises from astrocytes. It is ...

Lung Cancer: Analytical Tool

Lung Cancer: Analytical Tool

  • $ 8096
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Ovarian Cancer: Analytical Tool

August 2016 $ 8096

Renal Cancer: Analytical Tool

August 2016 $ 8096

Bladder Cancer: Analytical Tool

August 2016 $ 8096

Brain Cancer: Analytical Tool

August 2016 $ 8096

Breast Cancer: Analytical Tool

August 2016 $ 8096

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.